Skip to content Home / Companies / SPRY SPR
ARS Pharmaceuticals, Inc. (SPRY) XNAS PHARMACEUTICAL PREPARATIONS Net insider selling (90d)
Latest SPRY Insider Trades
About ARS Pharmaceuticals, Inc. (SPRY) ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Headquarters SAN DIEGO, CA
Employees 200
Listed 2022
Exchange XNAS https://www.ars-pharma.com SEC filings for SPRY on EDGAR
90-Day SEC Filing Activity Form 4 transaction type Transactions Shares Total value Open-market sale 2 28,355 $284K Grant or award 10 1,168,456 Option exercise 2 50,000
SPRY Insider Transactions (Form 4) 62 47 Form 4 filings on record, the earliest from Oct 10, 2024, newest first. Filing history page 1 of 2.
Date Insider Transaction Security Shares Price Value Jul 1, 2026 DC Donn Casale - Officer Grant or award Stock Option (right to buy) 898,456
Recent SPRY Form 8-K Filings 5
Recent SPRY Form 144 Notices of Proposed Sale 3 A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
Filed Filer Relationship Shares Market value Notice Aug 20, 2026 SARINA TANIMOTO Officer, 10% Stockholder 25,000 $148K View on EDGAR Aug 20, 2026 RICHARD LOWENTHAL Officer, Director, 10% Stockholder
SPRY Insider Trading - FAQ
What is the latest insider trade for SPRY? ARS Pharmaceuticals, Inc. (SPRY) had 12 insider filings in the last 90 days, with the most recent on 2026-07-02. The full record for SPRY runs to 47 Form 4 filings, the earliest from 2024-10-10. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying SPRY stock? No insider purchases of SPRY were filed in the last 90 days.
How many insiders are selling SPRY stock? 2 insider sales of SPRY were filed in the last 90 days, totaling $284K.
Where can I see SPRY SEC filings (Form 4, 10-K, 10-Q, 8-K)? This page tracks SPRY Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow SPRY insider buys? Create a free InsiderAlpha account and press Watch on this page to add SPRY to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Jul 2, 2026 - Donn Casale view on EDGAR Jun 26, 2026 - RA CAPITAL MANAGEMENT, L.P. view on EDGAR Jun 26, 2026 - Rajeev Dadoo view on EDGAR Jun 26, 2026 - Pratik Shah view on EDGAR Jun 26, 2026 - Michael Kelly view on EDGAR Jun 26, 2026 - Saqib Islam view on EDGAR Jun 26, 2026 - Peter A. Thompson view on EDGAR Jun 26, 2026 - Brent L. Saunders view on EDGAR Jun 26, 2026 - Phillip M. Schneider view on EDGAR
Related Companies - Recent Insider Activity What is SEC Form 4? The filing insiders must submit within two business days of a trade, and how to read its transaction codes. Track SPRY insider activity as it files Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
Sign up free $34K
Market cap $585.74M
P/E ratio -
Dividend yield -
Average volume 2.02M
52 week high $13.46
52 week low $4.91
Today's high $6.03
Today's low $5.86
Open $6.00
Volume 1.19M
Previous close $6.03
Shares outstanding 99.45M Market cap
$585.74M
200 employees
SPRY Insider Sentiment - Last 90 Days Share of open-market insider dollar volume that was buying versus selling, from SEC Form 4 filings.
0% Buying 100% Selling
0 insider purchases totaling $0 against 2 sales totaling $284K.
Most-Active SPRY Insiders - Last 90 Days 10 Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
Jun 24, 2026 RD Rajeev Dadoo Grant or award Stock Option (right to buy) 30,000 $0.00 -
Jun 24, 2026 PS Pratik Shah Grant or award Stock Option (right to buy) 30,000 $0.00 -
Jun 24, 2026 MK Michael Kelly Grant or award Stock Option (right to buy) 30,000 $0.00 -
Jun 24, 2026 SI Saqib Islam Grant or award Stock Option (right to buy) 30,000 $0.00 -
Jun 24, 2026 LS Laura Shawver Grant or award Stock Option (right to buy) 30,000 $0.00 -
Jun 12, 2026 EK Eric Karas - Officer Option exercise Common Stock 25,000 $1.50 $38K
Jun 12, 2026 EK Eric Karas - Officer Open-market sale Common Stock 25,000 $10.00 $250K
Jun 12, 2026 EK Eric Karas - Officer Option exercise Stock Option (Right to Buy) 25,000 $0.00 -
Nov 13, 2025 BD Brian Dorsey - Officer Open-market sale Common Stock 21,828 $8.71 $190K
Nov 13, 2025 BD Brian Dorsey - Officer Option exercise Stock Option (Right to Buy) 21,828 $0.00 -
Nov 13, 2025 BD Brian Dorsey - Officer Option exercise Common Stock 21,828 $0.64 $14K
Nov 12, 2025 JC Justin Chakma - Officer Option exercise Common Stock 30,000 $0.84 $25K
Nov 12, 2025 JC Justin Chakma - Officer Open-market sale Common Stock 30,000 $8.91 $267K
Nov 12, 2025 JC Justin Chakma - Officer Open-market sale Common Stock 136,380 $8.86 $1.21M
Nov 12, 2025 JC Justin Chakma - Officer Option exercise Stock Option (Right to Buy) 30,000 $0.00 -
Aug 21, 2025 KS Kathleen D. Scott - Officer Open-market sale Common Stock 12,500 $15.00 $188K
Aug 21, 2025 KS Kathleen D. Scott - Officer Option exercise Stock Option (Right to Buy) 12,500 $0.00 -
Aug 19, 2025 ST Sarina Tanimoto - Officer Open-market sale Common Stock 12,344 $14.03 $173K
Aug 20, 2025 ST Sarina Tanimoto - Officer Open-market sale Common Stock 37,656 $14.09 $531K
Jul 1, 2025 EK Eric Karas - Officer Option exercise Common Stock 15,000 $1.50 $23K
Jul 1, 2025 EK Eric Karas - Officer Open-market sale Common Stock 15,000 $16.99 $255K
Jul 1, 2025 EK Eric Karas - Officer Option exercise Stock Option (Right to Buy) 15,000 $0.00 -
Jun 27, 2025 JF James E. Flynn - 10% Owner Open-market sale Class A Common Stock 370,075 $18.46 $6.83M
Jun 27, 2025 JF James E. Flynn - 10% Owner Open-market sale Class A Common Stock 370,074 $18.46 $6.83M
May 20, 2025 BS Brent L. Saunders Option exercise Stock Option (Right to Buy) 120,000 $0.00 -
Dec 17, 2024 ST Sarina Tanimoto - Officer Open-market sale Common Stock 50,000 $11.67 $584K
Dec 17, 2024 ST Sarina Tanimoto - Officer Open-market sale Common Stock 50,000 $11.67 $584K
Dec 12, 2024 JC Justin Chakma - Officer Option exercise Common Stock 117,333 $0.84 $99K
Dec 12, 2024 JC Justin Chakma - Officer Open-market sale Common Stock 117,333 $12.27 $1.44M
Dec 13, 2024 JC Justin Chakma - Officer Option exercise Common Stock 27,272 $1.44 $39K
Dec 13, 2024 JC Justin Chakma - Officer Open-market sale Common Stock 27,272 $12.06 $329K
Dec 12, 2024 JC Justin Chakma - Officer Option exercise Stock Option (Right to Buy) 117,333 $0.00 -
Dec 13, 2024 JC Justin Chakma - Officer Option exercise Stock Option (Right to Buy) 27,272 $0.00 -
Dec 11, 2024 BD Brian Dorsey - Officer Option exercise Common Stock 15,000 $0.64 $10K
Dec 11, 2024 BD Brian Dorsey - Officer Open-market sale Common Stock 15,000 $12.43 $186K
Dec 12, 2024 BD Brian Dorsey - Officer Option exercise Common Stock 25,000 $0.64 $16K
Dec 12, 2024 BD Brian Dorsey - Officer Open-market sale Common Stock 25,000 $12.30 $307K
Dec 11, 2024 BD Brian Dorsey - Officer Option exercise Stock Option (Right to Buy) 15,000 $0.00 -
Dec 12, 2024 BD Brian Dorsey - Officer Option exercise Stock Option (Right to Buy) 25,000 $0.00 -
Dec 10, 2024 JC Justin Chakma - Officer Option exercise Common Stock 50,000 $0.84 $42K
Dec 10, 2024 JC Justin Chakma - Officer Open-market sale Common Stock 50,000 $13.15 $658K
Dec 10, 2024 JC Justin Chakma - Officer Option exercise Stock Option (Right to Buy) 50,000 $0.00 -
Dec 10, 2024 ST Sarina Tanimoto - Officer Open-market sale Common Stock 50,000 $13.17 $658K
Dec 10, 2024 ST Sarina Tanimoto - Officer Open-market sale Common Stock 50,000 $13.16 $658K
Aug 19, 2026 SARINA TANIMOTO Officer, 10% Stockholder 25,000 $161K View on EDGAR
SSY $IONS
IONIS PHARMACEUTICALS INC
Alexander A. Fitzpatrick - OfficerOpen-market sale
